Clinical and trichoscopic evaluation of trichloroacetic acid 35% vs phenol 88% peels in treatment of alopecia areata
- 21 May 2020
- journal article
- research article
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (1) , 143-149
Abstract
Background: Among alopecia areata (AA) treatments, contact irritants (anthralin) and topical immunotherapies (diphenylcyclopropenone) have been successfully used. Chemoexfoliation can potentially be utilized, acting as irritants and consecutively immunomodulators. Peels via therapeutic wounding provoke growth factors and cytokines that may induce hair regrowth.Aim: To evaluate and compare trichloroacetic acid (TCA) 35% and phenol 88% peels effectiveness and tolerability in patchy AA.Patients/Methods: This comparative, randomized, double‐blind study included 20 patients with multifocal patchy AA. In each patient, 2 patches were selected and randomized into group I (20 patches: TCA 35%) and group II (20 patches: phenol 88%). A session was performed every 3 weeks for 9 weeks. Response was assessed by two blinded observers as regards percentage of clinical improvement, severity of alopecia tool (SALT), and trichoscopic scaled scores for dystrophic and terminal hairs, respectively. Patients were scheduled for follow‐up visits over 6 months past treatment cessation.Results: A total of 19 patients completed the study and showed significant reduction in SALT score. TCA‐ and phenol‐treated patches demonstrated significant improvement in the percentage of clinical improvement, trichoscopic scale of dystrophic and terminal hairs. However, TCA was superior to phenol as it showed significant more reduction in trichoscopic score of dystrophic hairs and significant higher increase in terminal hairs. Phenol yielded significant higher discomfort than TCA. No relapse was detected.Conclusions: Trichloroacetic acid 35% and phenol 88% peels can be considered effective therapeutic modalities for patchy AA. TCA 35% represents a treatment of choice in terms of the efficacy and tolerability.Keywords
This publication has 19 references indexed in Scilit:
- Treatment of severe alopecia areata with baricitinibJAAD Case Reports, 2019
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and UniversalisJournal of Investigative Dermatology, 2018
- The Role of Micronutrients in Alopecia Areata: A ReviewAmerican Journal of Clinical Dermatology, 2017
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibitionNature Medicine, 2014
- Alopecia Areata: An Evidence-Based Treatment UpdateAmerican Journal of Clinical Dermatology, 2014
- Alopecia areata and suicide of childrenMedical Journal of Australia, 2014
- Evaluation of utility of phenol in alopecia areataInternational Journal of Trichology, 2013
- Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areataIndian Journal of Dermatology, Venereology and Leprology, 2013
- Alopecia areata treated with phenolisation and intravenous dexamethasone pulsesInternational Journal of Trichology, 2013
- Topical immunotherapy in alopecia areataInternational Journal of Trichology, 2010